Trump's Aid Cuts Stop South African HIV Vaccine Trials in Their Tracks By Nellie Peyton JOHANNESBURG (Reuters) - South African lab technician Nozipho Mlotshwa was waiting for the test results for ...

Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.

Relief groups have warned that halting programs such as PEPFAR could pose a risk to the lives of millions of people who will have to stop their HIV treatment, potentially opening the door to a HIV ...

South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work.